Activity of some mucolytics against bacterial adherence to mammalian cells

Applied Biochemistry and Biotechnology

Volumn 158, Issue 1, 2009, Pages 97-112

  Hafez, Mohamed M ^a   Aboulwafa, Mohammad M ^a   Yassien, Mahmoud A ^a   Hassouna, Nadia A ^a  

^a Ain Shams University   (Egypt)

Author keywords

Bacterial adherence; Mammalian cells; Mucolytics

Indexed keywords

AMMONIUM ACETATE; AMMONIUM CHLORIDE; BACTERIAL ADHERENCE; CARBOCYSTEINE; CHONDROITIN SULFATES; CLINICAL ISOLATES; DOSE-DEPENDENT MANNER; E. COLI; GUAIPHENESIN; IMMOBILIZED RECEPTORS; MAMMALIAN CELLS; MUCOLYTIC AGENT; P.AERUGINOSA; PRE-TREATMENT; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STRONG CORRELATION;

BACTERIA; BACTERIOLOGY; CELLS; CHLORINE COMPOUNDS; CYTOLOGY; ESCHERICHIA COLI; MAMMALS; SULFUR COMPOUNDS; SURFACE TREATMENT;

AMMONIUM COMPOUNDS;

AMBROXOL; AMMONIUM ACETATE; AMMONIUM CHLORIDE; BROMHEXINE; CARBOCISTEINE; DERMATAN SULFATE; GLYCOPROTEIN; GUAIFENESIN; HEPARIN; MUCIN; MUCOLYTIC AGENT; EXPECTORANT AGENT;

ANIMAL CELL; ARTICLE; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SCREENING; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MAMMAL CELL; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; ANIMAL; BACTERIUM; CELL LINE; DOSE RESPONSE; DRUG EFFECT;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; MAMMALIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACTERIA; BACTERIAL ADHESION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXPECTORANTS; HUMANS;

EID: 70349570581     PISSN: 02732289     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12010-008-8312-2     Document Type: Article

References (34)

1. Courtney, H. S., Li, Y., Dale, J. B., & Hasty, D. L. (1994). Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infection and Immunity, 62, 3937-3946.
2. Coleman, K. (2004). Recent advances in the treatment of Gram-positive infections. Drug Discovery Today: Therapeutic Strategies, 1(4), 455-460. doi:10.1016/j.ddstr.2004.08.015. (Pubitemid 40197591)
3. Schoolnik, G. K., O'Hanley, P., Lark, D., Normark, S., Vosti, K., & Falkow, S. (1987). Uropathogenic Escherichia coli: Molecular mechanisms of adherence. Advances in Experimental Medicine and Biology, 224, 53-62.
4. Stamm, W. E., Hooton, T. M., Johnson, J. R., Johnson, C., Stapleton, A., Roberts, P. L., et al. (1989). Urinary tract infections: From pathogenesis to treatment. The Journal of Infectious Diseases, 159(3), 400-406.
5. Mobley, H. L., Island, M. D., & Massad, G. (1994). Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. Kidney International, 47, 129-136.
6. Weinberg, A., Belton, C. M., Park, Y., & Lamont, R. J. (1997). Role of fimbriae in Porphyromonas gingivalis invasion of gingival epithelial cells. Infection and Immunity, 65(1), 313-316.
7. Svanborg, C., Orskov, F., & Orkov, I. (1994). Fimbriae and disease. In P. Klemm (Ed.), Fimbriae, adhesion, biogenesis and vaccines (pp. 239-254). Ann Arbor: CRC.
8. Ferrara, A., Dos Santos, C., & Lupi, A. (2001). Effect of different antibacterial agents and surfactant protein-A (SP-A) on adherence of some respiratory pathogens to bronchial epithelial cells. International Journal of Antimicrobial Agents, 17, 401-405. doi:10.1016/S0924-8579(00)00346-0. (Pubitemid 32401539)
9. Baskin, H., Dogan, Y., Bahar, I. H., & Yulug, N. (2002). Effect of subminimal inhibitory concentrations of three fluoroquinolones on adherence of uropathogenic strains of Escherichia coli. International Journal of Antimicrobial Agents, 19(1), 79-82. doi:10.1016/S0924-8579(01)00469-1. (Pubitemid 34119076)
10. Riise, G. C., Qvarfordt, I., Larsson, S., Eliasson, V., & Andersson, B. A. (2000). Inhibitory effect of acetylcysteine on adherence of Streptococcus pneumoniae and Haemophilus influenzae to human oropharyngeal epithelial cells in vitro. Respiration, 67(5), 552-558. doi:10.1159/000067473.
11. Zheng, C. H., Ahmed, K., Rikitomi, N., Martinez, G., & Nagatake, T. (1999). The effects of carboxymethylcysteine and N-acetylcysteine on the adherence of Moraxella catarrhalis to human pharyngeal epithelial cells. Microbiology and Immunology, 43(2), 107-113.
12. Olofsson, A.-C., Hermansson, M., & Elwing, H. (2003). N-Acetyl-L-Cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Applied and Environmental Microbiology, 69(8), 4814-4822. doi:10.1128/AEM.69.8.4814-4822.2003. (Pubitemid 36992945)
13. Hafez, M. M., Aboulwafa, M. M., Yassien, M. A., & Hassouna, N. A. (2008). Role of different classes of mammalian cell surface molecules in adherence of coagulase positive and coagulase negative staphylococci. Journal of Basic Microbiology, 48, 1-12.
14. Plotkowski, M. C., Saliba, A. M., Pereira, S. H., Cervante, M. P., & Bajolet-Laudinat, O. (1994). Pseudomonas aeruginosa selective adherence to and entry into human endothelial cells. Infection and Immunity, 62(12), 5456-5463.
15. Szkaradkiewicz, A., & Wal, M. (2001). Effect of cyclosporin on uropathogenic Escherichia coli adherence to human endothelial cells. International Journal of Antimicrobial Agents, 18(1), 89-91. doi:10.1016/S0924-8579(01)00341-7.
16. Yassien, M. A., & Khardori, N. (1998). Effects of ciprofloxacin and protamine sulfate on the adherence of Pseudomonas aeruginosa to human endothelial cells. Egyptian Journal Medicine Microbiology, 8, 611-617.
17. Balague, C. E., de Ruiz, C. S., Rey, R., de Duffard, A. E., & Nader-Macias, M. E. (2002). Effect of the herbicide 2,4-dichlorophenoxyacetic acid on uropathogenic Escherichia coli virulence factors. Toxicology, 177, 143-155. doi:10.1016/S0300-483X(02)00161-0. (Pubitemid 34804302)
18. Dziewanowska, K., Patti, J. M., Deobald, C. F., Bayles, K. W., Trumble, W. R., & Bohach, G. A. (1999). Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infection and Immunity, 67(9), 4673-4678.
19. Ofek, I., & Beachey, E. H. (1980). Bacterial adherence. Advances in Internal Medicine, 25, 503-532.
20. Beachey, E. H. (1981). Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. The Journal of Infectious Diseases, 143, 325-345.
21. Vranes, J. (1996). Inhibition of bacterial adherence possibilities of prevention and therapy. Lijecnicki Vjesnik, 118(7-8), 171-177.
22. Braga, P. C., Zuccotti, T., & Dal Sasso, M. (2001). Bacterial adhesiveness: Effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone. Chemotherapy, 47(3), 208-214. doi:10.1159/000063223. (Pubitemid 32304654)
23. Ndour, C. T., Ahmed, K., Nakagawa, T., Nakano, Y., Ichinose, A., Tarhan, G., et al. (2001). Modulating effects of mucoregulating drugs on the attachment of Haemophilus influenzae. Microbial Pathogenesis, 30(3), 121-127. doi:10.1006/mpat.2000.0417. (Pubitemid 32552993)
24. Ofek, I., & Doyle, R. J. (1994). Principles of bacterial adhesion. In I. Ofek, & R. J. Doyle (eds.), Bacterial Adhesion to Cells and Tissues (pp. 1-16). New York: Chapman & Hall.
25. Hazlett, L. D., Moon, M., Strejc, M., & Berk, R. S. (1987). Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to sacrificed cornea. Investigative Ophthalmology & Visual Science, 28, 1978-1985.
26. Ramphal, R., Carnoy, C., Fievre, S., Michalski, J. C., Houdret, N., Lamblin, G., et al. (1991). Pseudomonas aeruginosa recognizes carbohydrate chains containing type 1 (Galb1-3G1cNAc) or type 2 (Ga1β1-4G1cNAc) disaccharide units. Infection and Immunity, 59, 700-704.
27. Carret, G., Emonard, H., Fardel, G., Druguet, M., Herbage, D., & Flandrois, J. P. (1985). Gelatin and collagen binding to Staphylococcus aureus strains. Annales de l'Institut Pasteur. Microbiology, 136, 241-245. doi:10.1016/S0769-2609(85)80063-6. (Pubitemid 15003129)
28. Wadstrom, J. (1990). Studies on traumatic vasospasm in the central ear artery of the rabbit. Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery, 21, 1-42.
29. Chugh, T. D., Burns, G. J., Shuhaiber, H. J., & Bahr, G. M. (1990). Adherence of Staphylococcus epidermidis to fibrin-platelet clots in vitro mediated by lipoteichoic acid. Infection and Immunity, 58(2), 315-319.
30. Sanford, B. A., Thomas, V. L., Ramsay, M. A., Sanford, B. A., Thomas, V. L., & Ramsay, M. A. (1989). Binding of staphylococci to mucus in vivo and in vitro. Infection and Immunity, 57(12), 3735-3742.
31. Beuth, J., Ko, H. L., Schumacher-Perdreau, F., Peters, G., Heczko, P., & Pulverer, G. (1988). Hemagglutination by Staphylococcus saprophyticus and other coagulase-negative staphylococci. Microbial Pathogenesis, 4, 379-383. doi:10.1016/0882-4010(88)90065-4. (Pubitemid 18176401)
32. Johnson, J. R. (1991). Virulence factors in Escherichia coli urinary tract infection. Clinical Microbiology Reviews, 4, 80-128.
33. Connell, I., Agace, W., Klemm, P., Schembri, M., Marild, S., & Svanborg, C. (1996). Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proceedings of the National Academy of Sciences of the United States of America, 93(18), 9827-9832. doi:10.1073/pnas.93.18. 9827. (Pubitemid 26296694)
34. Olofsson, A.-C., Hermansson, M., & Elwing, H. (2005). Use of a quartz crystal microbalance to investigate the antiadhesive potential of N-Acetyl-L-cysteine. Applied and Environmental Microbiology, 71(5), 2705-2712. doi:10.1128/AEM.71.5.2705-2712.2005. (Pubitemid 40647017)